UTHR: United Therapeutics Corporation Stock

by  •  • Comments Off on UTHR: United Therapeutics Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12,525.56
Enterprise Value ($M) 11,128.36
Book Value ($M) 6,444.00
Book Value / Share 143.48
Price / Book 1.94
NCAV ($M) 2,953.90
NCAV / Share 65.77
Price / NCAV 4.24

Profitability (mra)
Return on Invested Capital (ROIC) 0.18
Return on Assets (ROA) 0.18
Return on Equity (ROE) 0.22

Liquidity (mrq)
Quick Ratio 5.03
Current Ratio 5.25

Balance Sheet (mrq) ($M)
Current Assets 3,873.90
Assets 7,364.00
Liabilities 920.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,877.40
Operating Income 1,446.30
Net Income 1,195.10
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 1,327.10
Cash from Investing 417.20
Cash from Financing -1,254.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-10 13G/A Wellington Management Group Llp 5.50 -35.06
02-05 13G State Street Corp 4.90 -1.71
11-08 13G/A Rothblatt Martine A 6.80 -18.10
06-10 13G/A Vanguard Group Inc 10.57 0.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 214,630 561,795 38.20
2025-04-10 113,256 483,375 23.43
2025-04-09 148,894 498,960 29.84
2025-04-08 170,352 446,936 38.12
2025-04-07 138,641 472,175 29.36

(click for more detail)

Similar Companies
TXMD – TherapeuticsMD, Inc. TYRA – Tyra Biosciences, Inc.
UBX – Unity Biotechnology, Inc. VERV – Verve Therapeutics, Inc.
VIGL – Vigil Neuroscience, Inc.


Financial data and stock pages provided by
Fintel.io